Suppr超能文献

人肝δ-氨基乙酰丙酸合酶:证明肝硬化患者和接受抗惊厥药物治疗的患者中该酶活性增加需要一个用于生成琥珀酰辅酶A的外源性系统。

Human hepatic delta-aminolaevulinate synthase: requirement of an exogenous system for succinyl-coenzyme A generation to demonstrate increased activity in cirrhotic and anticonvulsant-treated subjects.

作者信息

Bonkowsky H L, Pomeroy J S

出版信息

Clin Sci Mol Med. 1977 May;52(5):509-21. doi: 10.1042/cs0520509.

Abstract
  1. We have studied activity of delta-aminolaevulinate synthase in needle liver biopsy specimens obtained from 12 human cirrhotic subjects, five subjects who had ingested anticonvulsants and from control subjects. Liver iron concentrations and quantitative urinary excretions of porphyrins plus their precursors were also determined. 2. In liver homogenates from subjects of each group, addition of an exogenous system for generation of succinyl-coenzyme A (CoA), including succinic thiokinase, resulted in appreciable enhancement of activity beyond that obtained without this system. 3. Mean activities for delta-aminolaevulinate synthease were not significantly different among patient groups when assayed without the exogenous succinyl-CoA-generating system, but liver homogenates from cirrhotic patients and subjects ingesting anticonvulsants had significantly higher activities than control subjects in the presence of the succinyl-CoA-generating system. 4. Although mean liver iron concentration in the cirrhotic group was slightly higher than in control subjects, and in control subjects there was some correlation between liver iron concentration and activity of delta-aminolaevulinate synthase, variations in this activity could not be accounted for solely on the basis of chronic hepatic deposition. Nor were these variations ascribable to differences among subjects in ingestion of ethanol before biopsy or severity of hepatic inflammation as judged biochemically and histologically. 5. Cirrhotic subjects excreted more uro- and copro-porphyrin than control subjects, whereas subjects ingesting anticonvulsants excreted more delta-aminolaevulinic acid and porphobilinogen than control subjects. However, these increases were small and not sufficient to account for all the increased delta-aminolaevulinic acid which potentially could have been formed by these subjects. 6. These considerations raise the possibilities that in vivo: (a) rate of human hepatic synthesis of delta-aminolaevulinic acid is modulated by the supply of succinyl-CoA; (b) the rate of hepatic synthesis of haem is increased in cirrhotic patients and subjects ingesting anticonvulsants; (c) other important routes exist for disposition of haem precursors in these subjects, besides utilization for haem synthesis.
摘要
  1. 我们研究了从12名人类肝硬化患者、5名服用抗惊厥药的患者以及对照受试者获取的肝脏穿刺活检标本中δ-氨基-γ-酮戊酸合酶的活性。还测定了肝脏铁浓度以及卟啉及其前体的定量尿排泄量。

  2. 在每组受试者的肝脏匀浆中,添加包括琥珀酰硫激酶在内的用于生成琥珀酰辅酶A(CoA)的外源系统,导致活性明显增强,超过了不使用该系统时所获得的活性。

  3. 在不使用外源琥珀酰CoA生成系统进行测定时,各患者组之间δ-氨基-γ-酮戊酸合酶的平均活性无显著差异,但在存在琥珀酰CoA生成系统的情况下,肝硬化患者和服用抗惊厥药的受试者的肝脏匀浆活性显著高于对照受试者。

  4. 尽管肝硬化组的平均肝脏铁浓度略高于对照受试者,且在对照受试者中肝脏铁浓度与δ-氨基-γ-酮戊酸合酶活性之间存在一定相关性,但该活性的变化不能仅基于慢性肝脏沉积来解释。这些变化也不能归因于活检前受试者乙醇摄入量的差异或根据生化和组织学判断的肝脏炎症严重程度的差异。

  5. 肝硬化患者排泄的尿卟啉和粪卟啉比对照受试者多,而服用抗惊厥药的受试者排泄的δ-氨基-γ-酮戊酸和胆色素原比对照受试者多。然而,这些增加量很小,不足以解释这些受试者可能形成的所有增加的δ-氨基-γ-酮戊酸。

  6. 这些考虑因素提出了以下可能性:在体内:(a)人类肝脏合成δ-氨基-γ-酮戊酸的速率受琥珀酰CoA供应的调节;(b)肝硬化患者和服用抗惊厥药的受试者中血红素的肝脏合成速率增加;(c)除了用于血红素合成外,这些受试者中还存在其他处置血红素前体的重要途径。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验